相似文献
1
Association of MHC and rheumatoid arthritis. HLA-DR4 and rheumatoid arthritis: studies in mice and men.
Arthritis Res. 2000;2(3):208-11. doi: 10.1186/ar89. Epub 2000 Apr 25.
2
Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Arthritis Rheum. 2004 Jun;50(6):1984-95. doi: 10.1002/art.20285.
3
Genetic basis for rheumatoid arthritis.
Arch Immunol Ther Exp (Warsz). 1999;47(5):307-11.
4
Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.
Ann N Y Acad Sci. 2005 Jun;1051:263-70. doi: 10.1196/annals.1361.067.
5
Immunopathogenesis of collagen arthritis.
Springer Semin Immunopathol. 2003 Aug;25(1):3-18. doi: 10.1007/s00281-003-0127-1.
6
New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis.
Arthritis Rheum. 2007 Jan;56(1):69-78. doi: 10.1002/art.22213.
7
HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients.
Rheumatol Int. 1990;10(4):171-5. doi: 10.1007/BF02274843.
8
Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Am J Med Sci. 2004 Apr;327(4):169-79. doi: 10.1097/00000441-200404000-00002.
9
HLA-DRB1 gene sequences in HLA-DR4 positive and negative patients with rheumatoid arthritis.
Eur J Immunogenet. 1993 Apr;20(2):83-9. doi: 10.1111/j.1744-313x.1993.tb00096.x.
10
Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
J Immunol. 1998 Mar 15;160(6):2573-8.
引用本文的文献
1
Thyroid disease as a comorbidity in inflammatory rheumatic diseases.
Rheumatol Int. 2025 Feb 11;45(3):46. doi: 10.1007/s00296-025-05798-3.
2
Neutrophils in Inflammatory Bone Diseases.
Curr Osteoporos Rep. 2024 Apr;22(2):280-289. doi: 10.1007/s11914-024-00865-3. Epub 2024 Feb 29.
3
HLA-II-Dependent Neuroimmune Changes in Group A Streptococcal Necrotizing Fasciitis.
Pathogens. 2023 Jul 31;12(8):1000. doi: 10.3390/pathogens12081000.
4
MHC Class II Presentation in Autoimmunity.
Cells. 2023 Jan 14;12(2):314. doi: 10.3390/cells12020314.
5
A Strategy for Selective Deletion of Autoimmunity-Related T Cells by pMHC-Targeted Delivery.
Pharmaceutics. 2021 Oct 13;13(10):1669. doi: 10.3390/pharmaceutics13101669.
6
Electrochemical Immunosensor for the Early Detection of Rheumatoid Arthritis Biomarker: Anti-Cyclic Citrullinated Peptide Antibody in Human Serum Based on Avidin-Biotin System.
Sensors (Basel). 2020 Dec 28;21(1):124. doi: 10.3390/s21010124.
7
Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behçet's Disease with Arthritis.
Int J Mol Sci. 2019 Oct 11;20(20):5044. doi: 10.3390/ijms20205044.
8
14-3-3ζ-A Novel Immunogen Promotes Inflammatory Cytokine Production.
Front Immunol. 2019 Jul 24;10:1553. doi: 10.3389/fimmu.2019.01553. eCollection 2019.
9
Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome.
Int J Mol Sci. 2018 Aug 24;19(9):2508. doi: 10.3390/ijms19092508.
10
Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.
Cell Immunol. 2018 Sep;331:38-48. doi: 10.1016/j.cellimm.2018.05.003. Epub 2018 May 14.
本文引用的文献
1
Genetics of rheumatoid arthritis: confronting complexity.
Arthritis Res. 1999;1(1):37-44. doi: 10.1186/ar9. Epub 1999 Oct 26.
2
Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis.
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):291-6. doi: 10.1073/pnas.97.1.291.
3
Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis.
Arthritis Rheum. 1999 Dec;42(12):2569-76. doi: 10.1002/1529-0131(199912)42:12<2569::AID-ANR9>3.0.CO;2-3.
4
The immunologic homunculus in rheumatoid arthritis.
Arthritis Rheum. 1999 Dec;42(12):2499-506. doi: 10.1002/1529-0131(199912)42:12<2499::AID-ANR1>3.0.CO;2-R.
5
Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis.
Arthritis Rheum. 1999 Oct;42(10):2085-93. doi: 10.1002/1529-0131(199910)42:10<2085::AID-ANR8>3.0.CO;2-Z.
6
Transgenic mouse models of rheumatoid arthritis.
Immunol Rev. 1999 Jun;169:161-73. doi: 10.1111/j.1600-065x.1999.tb01314.x.
7
No support for HLA-DQ encoded susceptibility in rheumatoid arthritis.
Arthritis Rheum. 1999 Aug;42(8):1621-7. doi: 10.1002/1529-0131(199908)42:8<1621::AID-ANR9>3.0.CO;2-0.
8
Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study.
Arthritis Rheum. 1999 Apr;42(4):757-62. doi: 10.1002/1529-0131(199904)42:4<757::AID-ANR20>3.0.CO;2-X.
9
HLA-DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestations.
Eur J Immunogenet. 1999 Feb;26(1):19-27. doi: 10.1046/j.1365-2370.1999.00135.x.
10
HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis.
Hum Immunol. 1999 Feb;60(2):152-8. doi: 10.1016/s0198-8859(98)00101-3.
Zotero 插件